×
Entrez Id:
5293
Gene Symbol:
PIK3CD
PIK3CD
0.010
GeneticVariation
disease
BEFREE
SLE may be a novel phenotype of GOF mutation in PI3CKD gene (GOF PIK3CD ).
31045771
2019
×
Entrez Id:
618
Gene Symbol:
BCYRN1
BCYRN1
0.010
Biomarker
disease
BEFREE
SLE anti-BC abs belong to the IgG class of immunoglobulins and target both primate BC200 RNA and rodent BC1 RNA.
31405929
2019
×
Entrez Id:
3183
Gene Symbol:
HNRNPC
HNRNPC
0.010
Biomarker
disease
BEFREE
SLE anti-BC abs effectively compete with RNA transport factor heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) for DTE access and significantly diminish BC RNA delivery to synapto-dendritic sites of function.
31405929
2019
×
Entrez Id:
9987
Gene Symbol:
HNRNPDL
HNRNPDL
0.010
Biomarker
disease
BEFREE
SLE anti-BC abs effectively compete with RNA transport factor heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) for DTE access and significantly diminish BC RNA delivery to synapto-dendritic sites of function.
31405929
2019
×
Entrez Id:
7297
Gene Symbol:
TYK2
TYK2
0.040
GeneticVariation
disease
BEFREE
SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256 , rs12720270 , and rs280500 .
31434951
2019
×
Entrez Id:
114086
Gene Symbol:
DBA2
DBA2
0.010
Biomarker
disease
BEFREE
SLE was induced using two immunologic approaches: (1) immunization with the human monoclonal anti-DNA antibody expressing the 16/6Id, to which the DBA/2 strain is susceptible (responder) and the C57BL/6 strain is resistant (nonresponder); and (2) induction of autoimmune GVHD in B6D2F1 hosts by inoculation of parental DBA/2 (induces SLE) or C57BL/6 (does not induce SLE) T cells.
9325066
1997
×
Entrez Id:
1636
Gene Symbol:
ACE
ACE
0.040
GeneticVariation
disease
BEFREE
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE .
12043886
2002
×
Entrez Id:
3606
Gene Symbol:
IL18
IL18
0.050
Biomarker
disease
BEFREE
IL-18 is therefore suggested to play a crucial role in the inflammatory processes of renal disease in SLE .
12390326
2002
×
Entrez Id:
3586
Gene Symbol:
IL10
IL10
0.090
Biomarker
disease
BEFREE
IL10 /TNFalpha interaction influences susceptibility to DLE and the appearance of specific autoantibodies in SLE patients, whereas high TNFalpha producer genotypes represent a significant risk factor for SLE.
15800006
2005
×
Entrez Id:
10461
Gene Symbol:
MERTK
MERTK
0.010
GeneticVariation
disease
BEFREE
MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients.
16837475
2007
×
Entrez Id:
26191
Gene Symbol:
PTPN22
PTPN22
0.050
Biomarker
disease
BEFREE
PTPN22 : its role in SLE and autoimmunity.
18075792
2007
×
Entrez Id:
3606
Gene Symbol:
IL18
IL18
0.050
GeneticVariation
disease
BEFREE
IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE .
19387647
2009
KIR2DL5B
0.010
GeneticVariation
disease
BEFREE
KIR2DL5 was significantly associated with a decreased risk of SLE as well as an increased risk of infectious events overall in SLE patients.
20371502
2010
KIR2DL5A
0.010
GeneticVariation
disease
BEFREE
KIR2DL5 was significantly associated with a decreased risk of SLE as well as an increased risk of infectious events overall in SLE patients.
20371502
2010
HLA-DRB1
0.060
Biomarker
disease
BEFREE
HLA-DRB1 *15 confers susceptibility to juvenile SLE but is not associated with disease presentation: an Egyptian Study.
20380521
2010
×
Entrez Id:
114836
Gene Symbol:
SLAMF6
SLAMF6
0.010
Biomarker
disease
BEFREE
SLAMF6 -driven co-stimulation of human peripheral T cells is defective in SLE T cells.
21231893
2011
×
Entrez Id:
4783
Gene Symbol:
NFIL3
NFIL3
0.010
AlteredExpression
disease
BEFREE
E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
23340290
2013
×
Entrez Id:
26191
Gene Symbol:
PTPN22
PTPN22
0.050
GeneticVariation
disease
BEFREE
PTPN22 1858C>T gene polymorphism in patients with SLE : association with serological and clinical results.
24985973
2014
×
Entrez Id:
6375
Gene Symbol:
XCL1
XCL1
0.010
Biomarker
disease
BEFREE
ATAC -seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells.
27249108
2016
×
Entrez Id:
640
Gene Symbol:
BLK
BLK
0.030
GeneticVariation
disease
BEFREE
BLK pathway-associated rs13277113 GA genotype is more frequent in SLE patients and associated with low gene expression and increased flares.
27864698
2017
×
Entrez Id:
9447
Gene Symbol:
AIM2
AIM2
0.020
Biomarker
disease
BEFREE
Absent in Melanoma 2 proteins in SLE .
28062222
2017
×
Entrez Id:
7128
Gene Symbol:
TNFAIP3
TNFAIP3
0.020
AlteredExpression
disease
BEFREE
TNFAIP3 mRNA was significantly downregulated in the CD4 + T cells of SLE patients compared with NCs.
28158872
2017
×
Entrez Id:
6777
Gene Symbol:
STAT5B
STAT5B
0.010
PosttranslationalModification
disease
BEFREE
STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
28254841
2017
×
Entrez Id:
6776
Gene Symbol:
STAT5A
STAT5A
0.010
PosttranslationalModification
disease
BEFREE
STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
28254841
2017
×
Entrez Id:
442896
Gene Symbol:
MIR302D
MIR302D
0.010
AlteredExpression
disease
BEFREE
MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE .
28318807
2017